J. Ferlay, I. Soerjomataram, M. Ervik, R. Dikshit, S. Eser et al., Cancer Incidence and Mortality Worldwide: IARC CancerBase No Available from, International Agency for Research on Cancer, 2013.

N. Munoz, X. Castellsague, A. De-gonzalez, and L. Gissmann, Chapter 1: HPV in the etiology of human cancer, Vaccine, vol.24, pp.3-4, 2006.

J. Kim, N. Campos, O. Shea, M. Diaz, M. Mutyaba et al., Model-Based Impact and Cost-Effectiveness of Cervical Cancer Prevention in Sub-Saharan Africa, Vaccine, vol.31, pp.31-60
DOI : 10.1016/j.vaccine.2012.07.093

S. Franceschi, R. Herrero, G. Clifford, P. Snijders, A. Arslan et al., Variations in the age-specific curves of human papillomavirus prevalence in women worldwide, International Journal of Cancer, vol.91, issue.11, pp.2677-2684, 2006.
DOI : 10.1002/ijc.22241

N. Li, S. Franceschi, R. Howell-jones, P. Snijders, and G. Clifford, Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication, International Journal of Cancer, vol.201, issue.Suppl. 10, pp.927-935, 2011.
DOI : 10.1002/ijc.25396

L. Markowitz, S. Hariri, E. Unger, M. Saraiya, S. Datta et al., Post-licensure monitoring of HPV vaccine in the United States, Vaccine, vol.28, issue.30, pp.4731-4737, 2010.
DOI : 10.1016/j.vaccine.2010.02.019

R. Ruland, C. Prugger, R. Schiffer, M. Regidor, and R. Lelle, Prevalence of human papilloma virus infection in women in rural Ethiopia, European Journal of Epidemiology, vol.6, issue.5, pp.727-729, 2006.
DOI : 10.1007/s10654-006-9055-4

R. Saiki, D. Gelfand, S. Stoffel, S. Scharf, R. Higuchi et al., Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase, Science, vol.239, issue.4839, pp.487-491, 1988.
DOI : 10.1126/science.2448875

D. Geraets, D. Heideman, M. De-koning, P. Snijders, C. Meijer et al., High genotyping concordance between the digene HPV Genotyping RH Test and the Reverse Line Blot genotyping assay on GP5+/6+-PCR products, Journal of Clinical Virology, vol.46, pp.46-62, 2009.
DOI : 10.1016/S1386-6532(09)70296-3

B. Kleter, L. Van-doorn, L. Schrauwen, A. Molijn, S. Sastrowijoto et al., Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus, J Clin Microbiol, vol.37, pp.2508-2517, 1999.

R. Doll, P. Payne, and J. Waterhouse, Cancer incidence in five continents: a technical report, International Union Against Cancer (IUAC), 1966.

M. Schiffman, R. Herrero, R. Desalle, A. Hildesheim, S. Wacholder et al., The carcinogenicity of human papillomavirus types reflects viral evolution, Virology, vol.337, issue.1, pp.76-84, 2005.
DOI : 10.1016/j.virol.2005.04.002

C. Schellenbacher, R. Roden, and R. Kirnbauer, Chimeric L1-L2 Virus-Like Particles as Potential Broad-Spectrum Human Papillomavirus Vaccines, Journal of Virology, vol.83, issue.19, pp.10085-10095, 2009.
DOI : 10.1128/JVI.01088-09
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2748020

J. Smith, A. Melendy, R. Rana, and J. Pimenta, Age-Specific Prevalence of Infection with Human Papillomavirus in Females: A Global Review, Journal of Adolescent Health, vol.43, issue.4
DOI : 10.1016/j.jadohealth.2008.07.009

J. Gage, K. Ajenifuja, N. Wentzensen, A. Adepiti, C. Eklund et al., The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: Implications for screen-and-treat strategies, International Journal of Cancer, vol.95, issue.Suppl 3, pp.2111-2117, 2012.
DOI : 10.1002/ijc.26211

M. Safaeian, M. Kiduggavu, P. Gravitt, S. Gange, J. Ssekasanvu et al., Prevalence and risk factors for carcinogenic human papillomavirus infections in rural Rakai, Uganda, Sexually Transmitted Infections, vol.84, issue.4, pp.306-311, 2008.
DOI : 10.1136/sti.2007.027318

X. Castellsague, C. Menendez, M. Loscertales, J. Kornegay, F. Santos et al., Human papillomavirus genotypes in rural Mozambique, The Lancet, vol.358, issue.9291, pp.1429-1430, 2001.
DOI : 10.1016/S0140-6736(01)06523-0

D. Vuyst, H. Clifford, G. Li, N. Franceschi, and S. , HPV infection in Europe, European Journal of Cancer, vol.45, issue.15, pp.2632-2639, 2009.
DOI : 10.1016/j.ejca.2009.07.019

S. De-sanjose, M. Diaz, X. Castellsague, G. Clifford, L. Bruni et al., Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis, The Lancet Infectious Diseases, vol.7, issue.7, pp.453-459, 2007.
DOI : 10.1016/S1473-3099(07)70158-5

P. Castle, M. Schiffman, R. Herrero, A. Hildesheim, A. Rodriguez et al., A Prospective Study of Age Trends in Cervical Human Papillomavirus Acquisition and Persistence in Guanacaste, Costa Rica, The Journal of Infectious Diseases, vol.191, issue.11, pp.1808-1816, 2005.
DOI : 10.1086/428779

M. Clarke, J. Gage, K. Ajenifuja, N. Wentzensen, A. Adepiti et al., A population-based cross-sectional study of age-specific risk factors for high risk human papillomavirus prevalence in rural Nigeria, Infectious Agents and Cancer, vol.6, issue.1, p.12
DOI : 10.1016/j.jpag.2009.01.002

S. Bissett, E. Draper, R. Myers, A. Godi, and S. Beddows, Cross-neutralizing antibodies elicited by the Cervarix?? human papillomavirus vaccine display a range of Alpha-9 inter-type specificities, Vaccine, vol.32, issue.10, pp.1139-1146, 2014.
DOI : 10.1016/j.vaccine.2014.01.008

L. Barzon, L. Squarzon, S. Masiero, M. Pacenti, G. Marcati et al., Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes, Vaccine, vol.32, issue.41, pp.5357-5362, 2014.
DOI : 10.1016/j.vaccine.2014.07.014

P. Guan, R. Howell-jones, N. Li, L. Bruni, S. De-sanjose et al., Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer, International Journal of Cancer, vol.9, issue.10, pp.2349-2359, 2012.
DOI : 10.1002/ijc.27485

C. Banura, F. Mirembe, J. Orem, A. Mbonye, S. Kasasa et al., Prevalence, incidence and risk factors for anogenital warts in Sub Saharan Africa: a systematic review and meta analysis, Infectious Agents and Cancer, vol.8, issue.1, p.27
DOI : 10.1097/00007435-199301000-00003

D. Dames, C. Ragin, A. Griffith-bowe, P. Gomez, and R. Butler, The prevalence of cervical cytology abnormalities and human papillomavirus in women infected with the human immunodeficiency virus, Infectious Agents and Cancer, vol.4, issue.Suppl 1, p.8, 2009.
DOI : 10.1186/1750-9378-4-S1-S8

E. Lazcano-ponce, R. Herrero, N. Munoz, A. Cruz, K. Shah et al., Epidemiology of HPV infection among Mexican women with normal cervical cytology, International Journal of Cancer, vol.91, issue.3, pp.412-420, 2001.
DOI : 10.1002/1097-0215(20010201)91:3<412::AID-IJC1071>3.0.CO;2-M

S. Vaccarella, R. Herrero, M. Dai, P. Snijders, C. Meijer et al., Reproductive Factors, Oral Contraceptive Use, and Human Papillomavirus Infection: Pooled Analysis of the IARC HPV Prevalence Surveys, Cancer Epidemiology Biomarkers & Prevention, vol.15, issue.11, pp.2148-2153, 2006.
DOI : 10.1158/1055-9965.EPI-06-0556

C. Meijer, J. Berkhof, P. Castle, A. Hesselink, E. Franco et al., Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older, International Journal of Cancer, vol.19, issue.3, pp.516-520, 2009.
DOI : 10.1002/ijc.24010

M. Safaeian, R. Herrero, A. Hildesheim, W. Quint, E. Freer et al., Comparison of the SPF10-LiPA System to the Hybrid Capture 2 Assay for Detection of Carcinogenic Human Papillomavirus Genotypes among 5,683 Young Women in Guanacaste, Costa Rica, Journal of Clinical Microbiology, vol.45, issue.5, pp.1447-1454, 2007.
DOI : 10.1128/JCM.02580-06

P. Castle, D. Solomon, C. Wheeler, P. Gravitt, S. Wacholder et al., Human Papillomavirus Genotype Specificity of Hybrid Capture 2, Journal of Clinical Microbiology, vol.46, issue.8, pp.2595-2604, 2008.
DOI : 10.1128/JCM.00824-08

P. De-cremoux, J. Coste, X. Sastre-garau, M. Thioux, C. Bouillac et al., Efficiency of the Hybrid Capture 2 HPV DNA Test in Cervical Cancer Screening, American Journal of Clinical Pathology, vol.120, issue.4, pp.492-499, 2003.
DOI : 10.1309/XFUCPP6M5XUA94B8

A. Hesselink, N. Bulkmans, J. Berkhof, A. Lorincz, C. Meijer et al., Cross-Sectional Comparison of an Automated Hybrid Capture 2 Assay and the Consensus GP5+/6+ PCR Method in a Population-Based Cervical Screening Program, Journal of Clinical Microbiology, vol.44, issue.10, pp.3680-3685, 2006.
DOI : 10.1128/JCM.02078-05

. Bannurah, Cervical human papillomavirus prevalence and genotype distribution among hybrid capture 2 positive women 15 to 64??years of age in the Gurage zone, rural Ethiopia, Infectious Agents and Cancer, vol.9, issue.1, p.33, 2014.
DOI : 10.1128/JCM.02078-05
URL : https://hal.archives-ouvertes.fr/inserm-01196791